Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Asia Pac J Clin Nutr. 2014;23(2):205–209. doi: 10.6133/apjcn.2014.23.2.19

Table 1.

Dietary isoflavone intake and urinary isoflavonoid excretion during the study

All (N=256) BEAN1 (N=174) BEAN2 (N=82)

Baseline
(all)
Low soy
(control)
High soy
(intervention)
Baseline
(all)
Low soy
(control)
High soy
(intervention)
Baseline
(all)
Low soy High soy

Samples, N 256 573 556 174 328 313 82 245 243
Dietary isoflavone intake mg/day 2.3 (0.3–7.4) 0.2 (0.1–2.3) 60.4 (49.8–74.6) 2.7 (1.1–6.6) 0.2 (0.1–4.3) 56.9 (49.8–72.4) 0.5 (0.1–31.3) 0.2 (0.1–1.1) 67.7 (48.5–85.3)
Urinary isoflavonoids nmol/mg creatinine 0.4 (0.0–4.2) 1.0 (0.0–4.4) 32.4 (11.1–70.3) 0.0 (0.0–4.1) 0.9 (0.0–4.6) 28.6 (8.4–63.6) 0.9 (0.3–4.7) 1.1 (0.3–4.2) 44.2 (18.3–79.4)
Adherence to dietary intervention -- 84% 85% -- 83% 87% -- 86% 84%
Correlation coefficients between dietary isoflavone intake and urinary isoflavonoid excretion (p value)
Low or high soy only -- 0.05 (p=0.20) 0.06 (p=0.17) -- 0.07 (p=0.21) 0.06 (p=0.30) -- 0.06 (p=0.35) 0.01 (p=0.84)
Low and high soy -- 0.51 (p<0.0001) -- 0.49 (p<0.0001) -- 0.55 (p<0.0001)
Area under the receiver operating characteristic curve (p value)*
Low or high soy only -- 0.565 (p=0.02) 0.573 (p=0.03) -- 0.555 (p<0.001) 0.537 (p=0.32) -- 0.618 (p=0.06) 0.627 (p=0.01)
Low and high soy -- 0.850 (p<0.0001) -- 0.822 (p<0.0001) -- 0.899 (p<0.0001)

Data are presented as median (lower - upper quartile) unless otherwise noted.

Adherence to dietary intervention was defined using estimated dietary isoflavone intake (DII) from 24-hour dietary recalls as >40 mg/day during the high soy diet and <10 mg/day during the low soy diet.

*

P values and areas under the receiver operating characteristic curve were calculated in logistic regression models with log-transformed urinary isoflavonoid excretion as a continuous independent variable and dietary intervention (high-soy or low-soy diet) as a binary outcome variable.